Hydrochlorothiazide compared to chlorthalidone in reduction of urinary calcium in patients with kidney stones

Urological Research

Volumn 41, Issue 4, 2013, Pages 315-322

  Wolfgram, Dawn F ^a   Gundu, Vinod ^b   Astor, Brad C ^c   Jhagroo, R Allan ^c  

^a CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b State University of New York Upstate Medical University: College of Medicine   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Chlorthalidone; Hydrochlorothiazide; Nephrolithiasis; Secondary preventi; Urinary calcium

Indexed keywords

CHLORTALIDONE; CITRIC ACID; HYDROCHLOROTHIAZIDE;

ADULT; ARTICLE; CALCIUM URINE LEVEL; CONTROLLED STUDY; CREATININE URINE LEVEL; DEMOGRAPHY; DRUG EFFECT; ELECTROLYTE URINE LEVEL; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERCALCEMIA; HYPOKALEMIA; HYPOTENSION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NEPHROLITHIASIS; OBSERVATIONAL STUDY; PHOSPHATE BLOOD LEVEL; POTASSIUM URINE LEVEL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SODIUM URINE LEVEL; TREATMENT DURATION; TREATMENT OUTCOME; URIC ACID STONE; URIC ACID URINE LEVEL; COMORBIDITY; DRUG EFFICACY; MIDDLE AGED;

EID: 84892374073     PISSN: 03005623     EISSN: 14340879     Source Type: Journal    
DOI: 10.1007/s00240-013-0568-5     Document Type: Article

References (25)

1. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC (2003) Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 63(5):1817-1823. doi: 10.1046/j.1523-1755.2003.00917.x
2. Scales CD Jr, Smith AC, Hanley JM, Saigal CS (2012) Prevalence of kidney stones in the United States. Eur Urol 62(1):160-165. doi:10.1016/j.eururo.2012. 03.052
3. Pearle MS, Calhoun EA, Curhan GC (2005) Urologic diseases in America project: Urolithiasis. J Urol 173(3):848-857. doi:10.1097/ 01.ju.0000152082. 14384.d7
4. Semins MJ, Matlaga BR (2010) Medical evaluation and management of urolithiasis. Ther Adv Urol 2(1):3-9. doi:10.1177/ 1756287210369121
5. Uribarri J, Oh MS, Carroll HJ (1989) The first kidney stone. Ann Intern Med 111(12):1006-1009
6. Rule AD, Krambeck AE, Lieske JC (2011) Chronic kidney disease in kidney stone formers. Clin J Am Soc Nephrol 6(8): 2069-2075. doi:10.2215/CJN.10651110
7. Rule AD, Roger VL, Melton LJ 3rd, Bergstralh EJ, Li X, Peyser PA, Krambeck AE, Lieske JC (2010) Kidney stones associate with increased risk for myocardial infarction. J Am Soc Nephrol 21(10):1641-1644. doi:10.1681/ASN. 2010030253
8. Yendt ER, Guay GF, Garcia DA (1970) The use of thiazides in the prevention of renal calculi. Can Med Assoc J 102(6):614-620
9. Laerum E, Larsen S (1984) Thiazide prophylaxis of urolithiasis. A double-blind study in general practice. Acta Med Scand 215(4):383-389
10. Ettinger B, Citron JT, Livermore B, Dolman LI (1988) Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. J Urol 139(4):679-684
11. Fernandez-Rodriguez A, Arrabal-Martin M, Garcia-Ruiz MJ, Arrabal-Polo MA, Pichardo-Pichardo S, Zuluaga-Gomez A (2006) The role of thiazides in the prophylaxis of recurrent calcium lithiasis. Actas Urol Esp 30(3):305-309
12. Reilly RF, Peixoto AJ, Desir GV (2010) The evidence-based use of thiazide diuretics in hypertension and nephrolithiasis. Clin J Am Soc Nephrol 5(10):1893-1903. doi:10.2215/CJN.04670510
13. Vigen R, Weideman RA, Reilly RF (2011) Thiazides diuretics in the treatment of nephrolithiasis: Are we using them in an evidence-based fashion? Int Urol Nephrol 43(3):813-819. doi: 10.1007/s11255-010-9824-6
14. ALLHAT Collaborative Research Group (2000) Major cardiovascular events in hypertensive patients randomized to doxazosin vs. chlorthalidone: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 283 (15):1967-1975
15. Flack JM, Cushman WC (1996) Evidence for the efficacy of lowdose diuretic monotherapy. Am J Med 101(3):53S-60S
16. Floge J, Johnson RJ, Feehally J (2010) Comprehensive clinical nephrology. Saunders Elsevier, St. Louis
17. Curhan GC, Taylor EN (2008) 24-h uric acid excretion and the risk of kidney stones. Kidney Int 73(4):489-496. doi:10.1038/ sj.ki.5002708
18. Yendt ER, Cohanim M (1978) Prevention of calcium stones with thiazides. Kidney Int 13(5):397-409
19. Ernst ME, Carter BL, Goerdt CJ, Steffensmeier JJ, Phillips BB, Zimmerman MB, Bergus GR (2006) Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension 47(3):352-358. doi:10.1161/01.HYP.0000203309.07140.d3
20. ErnstME, Carter BL, Zheng S, Grimm RH Jr (2010)Meta-analysis of dose-response characteristics of hydrochlorothiazide and chlorthalidone: Effects on systolic blood pressure and potassium. Am J Hypertens 23(4):440-446. doi:10.1038/ajh.2010.1
21. Carter BL, Ernst ME, Cohen JD (2004) Hydrochlorothiazide versus chlorthalidone: Evidence supporting their interchangeability. Hypertension 43(1):4-9. doi:10.1161/01.HYP.0000103632.19915.0E
22. SHEP Cooperative Research Group (1991) Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 265 (24):3255-3264
23. Sumiye L, Vivian AS, Frisof KB, Podany EC (1981) Potassium loss associated with hydrochlorothiazide versus chlorthalidone. Clin Ther 4(4):308-320
24. Dhalla IA, Gomes T, Zhan Y, Nagge J, Persaud N, Hellings C, Mamdami MM, Juurlink DN (2013) Chlorthalidone versus hydrochlorothiazide for treatment of hypertension in older adults. Ann Intern Med 158(6):447-455
25. Zuckerman JM, Assimos DG (2009) Hypocitraturia: Pathophysiology and medical management. Rev urol 11(3):134-144